Suzhou Zelgen Biopharmaceuticals , Ltd. Current Assets

As of the most recent data (June 2026), 688266.SS shows a current assets of $3B. That compares with $2.6B in the prior-year period — up 16.1% year over year. Scroll down for historical charts and peer comparison views.

Compared with the year-ago period, 688266.SS's current assets is now $3B (was $2.6B) — a 16.1% year-over-year increase. Pairing that YoY change with peer averages gives a clearer picture of whether Suzhou Zelgen Biopharmaceuticals , Ltd. is outperforming or lagging.

Tracking 688266.SS's current assets over time shows whether Suzhou Zelgen Biopharmaceuticals , Ltd. is scaling, shrinking, or reshaping that part of the business. The current reading is $3B That compares with $2.6B in the prior-year period — up 16.1% year over year. Multi-quarter patterns matter more than any single print, which is why this page emphasizes history and peer comparison charts.

Besides this current assets page, Stockcircle has Suzhou Zelgen Biopharmaceuticals , Ltd.'s full stock overview, other financial metrics, insider and congress trade tabs, and tools to follow the stock. Together they help you connect current assets (currently $3B) with ownership activity and broader fundamentals.

Suzhou Zelgen Biopharmaceuticals , Ltd.'s current assets is $3B; compare it with other Healthcare names on the peer chart. Typical ranges vary by sub-industry, so always sanity-check against the closest competitors, not just the whole sector bucket.